Intra-Cellular Therapies Inc. ( ITCI) - Key Metrics
Stock symbol ITCI is outdated, potentially delisted? Maybe it is available on other exchange?
ITCI Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q4 | $1.93 | -$0.16 | -$0.13 | -$0.12 |
| 2024Q3 | $1.66 | -$0.25 | -$0.25 | -$0.26 |
| 2024Q2 | $1.56 | -$0.16 | $0.01 | $0 |
| 2024Q1 | $1.50 | -$0.16 | -$0.35 | -$0.35 |
| 2023Q4 | $1.37 | -$0.30 | -$0.02 | -$0.02 |
ITCI Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q4 | ? | -127.53 |
| 2024Q3 | ? | -73.50 |
| 2024Q2 | ? | -108.69 |
| 2024Q1 | ? | -108.44 |
| 2023Q4 | ? | -60.32 |
ITCI
Price: $131.87
52 week price:
Earnings Per Share: -0.73 USD
P/E Ratio: -180.64
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 307914
Ebitda: -22.8 millionMarket Capitalization: 14.0 billion